Crosscheck

Your medical. Crosschecked.

Bones

Zoledronic acid

Bisphosphonate (infusion)
Other names: Reclast

FAA guidance

Acceptable with conditions.

Wait

1 week

initial observation

There is more to this wait.

Examiner

The examiner can issue when the document's criteria are met

FAA label

ACCEPTABLE

Source: FAA, Osteoporosis Medications. FAA date 26 August 2026. Checked by Crosscheck 14 October 2026

The FAA lists zoledronic acid (Reclast) infusions as acceptable osteoporosis medication when the certification criteria are met, with a one-week initial observation.

Track your medications
More detail: zoledronic acidThe rest of the wait, and the FAA rules behind this answerOpen

Wait

  • no wait after later doses
  • 7 days after starting: ground observation
Show the FAA's words: zoledronic acidThe official FAA wording: one passage, each with its document and dateOpen
FAA, Osteoporosis Medications · FAA date 26 August 2026
ACCEPTABLE Osteoporosis Medications (when certification criteria are met). Bisphosphonate (infusion): zoledronic acid (Reclast), 1 week, None
Sources and dates: zoledronic acidOne FAA document, with the FAA's date and when Crosscheck checked itOpen

See also

Medication guidance alone does not determine whether a pilot is medically qualified to fly. The underlying condition, dosage, side effects, medication combinations, and certification history may affect FAA eligibility.

For informational purposes only. Not legal or medical advice.